Terminated PHASE3 INTERVENTIONAL NCT00003803

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

A Randomized Phase III Study Comparing Induction Chemotherapy to Daily Low Dose Cisplatin Both Combined With High Dose Radiotherapy Using Concomitant Boost Technique in Patients With Inoperable Non-Small Cell Lung Cancer Stage I, II, and Low Volume Stage III

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Lung Cancer

Interventions cisplatin gemcitabine hydrochloride radiation therapy

Updated 6 times since 2017 Last updated: Jul 17, 2012 Started: Feb 28, 1999 Primary completion: Mar 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

low accrual

Other terminated trials from European Organisation for Research and Treatment of Cancer - EORTC

See all terminations from European Organisation for Research and Treatment of Cancer - EORTC

Other Lung Cancer trials with similar outcome

Browse all Lung Cancer trials

Listed as NCT00003803, this PHASE3 trial focuses on Lung Cancer and remains terminated or withdrawn. Sponsored by European Organisation for Research and Treatment of Cancer - EORTC, it has been updated 6 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Feb 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

's-Gravenhage (Den Haag, the Hague), Netherlands , Amsterdam, Netherlands , Antwerp, Belgium , Apeldoorn, Netherlands , Breda, Netherlands , Delft, Netherlands , Deventer, Netherlands , Edinburgh, United Kingdom , Eindhoven, Netherlands , Grenoble, France and 4 more locations